Dipna Pharmachem Ltd Share Price

Pharmaceuticals

Small Cap ISIN: INE0MC401013

As on 17 April 2025 at 21:10 IST

₹ 17.42

+ 0.76

(4.56%)

Sell Buy

Over 1 Month

30.36%

Over 6 Months

120.66%

Over 1 Year

107.73%

Over 3 Years

-39.29%

Dipna Pharmachem Ltd Summary

Close ₹17.42

Open ₹16.66

High ₹17.49

Low ₹16.30

Volume 69,000

Net Turnover (in Cr) ₹0.11

52Wk High ₹18.06

52Wk Low ₹6.40

52Wk High / Low

6.40

18.06

Dipna Pharmachem Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹40.06

EPS (TTM) 0.45

Book Value (BV) 15.60

Div. Yield -

P/E (TTM) 37.02

Price/Book Value 1.07

Delivery % 73.53 %

Face Value 10

Key Ratios

PE Ratio 20.93

PB Ratio 0.60

EV to Sales 0.17

PEG Ratio -0.51

ROA 1.91

ROE 3.52

Debt-Equity 0.57

Net Profit Margin 0.66

Operating Profit Margin 2.10

Dipna Pharmachem Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	164.34	99.93	72.77	31.02	30.55
Total Expenses	162.92	98.55	71.19	30.96	30.49
Profit Before Tax	1.42	1.38	1.57	0.06	0.06
Profit After Tax	1.09	0.91	1.17	0.02	0.06
Operating Profit After Depreciation	3.42	2.34	2.18	0.41	0.06

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	0.04	0.04	0.04	0.04	0.04
Total Non Current Assets	0.04	0.04	0.04	0.04	0.04
Total Current Assets	132.87	77.52	36.19	24.75	18.40
Total Assets	132.91	77.56	36.23	24.79	18.44
Total Shareholder's Fund	37.52	24.36	1.74	0.57	0.55

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash From Operating Activities	-5.42	-20.98	2.81	-2.43	-3.12
Net Cash Used In Investing Activities	-0.01	-0.01	-0.01	-	0.01
Net Cash Used In Financing Activities	13.62	26.47	-2.84	2.50	3.17

No data available

Dipna Pharmachem Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 16.19

S2 15.73

S3 14.79

Pivot 17.13

R1 17.59

R2 18.53

R3 18.99

Moving Average

20 SMA 14.47

50 SMA 13.83

100 SMA 12.48

200 SMA 10.11

Dipna Pharmachem Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

EGM Date: 04 Feb 2023

Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today i.e. 11th January, 2023 at the Registered Office of the Company which commenced at 5:30 P.M. and concluded at 6:00 P.M., has decided to hold Extra Ordinary General Meeting of the Company on Saturday, 4th February, 2023 at 4:00 P.M. We hereby inform you that the Board of Directors of the Company has decided to call Extra Ordinary General Meeting of the Company to be held on Saturday, 4th February, 2023 at 4:00 P.M through VC/OAVM. Notice of Extra Ordinary General Meeting of the Company is enclosed. The Company is providing remote E-voting facility to all the shareholders of the Company. The Company has set 28th January, 2023 as the 'Cut-off Date' for taking record of the shareholders of the Company who will be eligible for casting their vote on the resolution to be passed in Extra Ordinary General Meeting for remote E-voting. The remote e-voting period begins on 1st February, 2023 at 9:00 A.M. and ends on 3rd February, 2023 at 5:00 P.M. (As Per BSE Announcement Dated on 12.01.2023) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the members of the Company at their Extra Ordinary General Meeting of the Company held today i.e. on 4th February, 2023 through Video Conferencing (VC) / Other Audio Video Means (OAVM) which was commenced on 4:07 P.M. and concluded on 4:14 P.M., have discussed and considered the businesses mentioned in the notice of Extra Ordinary General Meeting. (As Per BSE Announcement Dated on 04/02/2023) Pursuant to Section 108 and 109 of the Company Act, 2013 read with Rule 20 & 21 of the Companies (Management and Administration) Rules, 2014, we are submitting herewith the Scrutinizer Report of the Extraordinary General Meeting of the Company be held i.e. Saturday, 4th February, 2023 at 4:00 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380055. (As Per BSE Announcement Dated on 07.02.2023)

EGM Date: 03 Jan 2024

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company held today i.e. Friday, 8th December, 2023 at the Registered Office of the Company which commenced at 11:00 A.M. and concluded at 12:00 P.M inter-alia has: 1. Considered and approved increase in Authorised Share Capital upto Rs. 25,00,00,000/- (Rupees Twenty-Five Crores Only) by alteration of the capital clause in the Memorandum of Association of the Company. 2. Decided to hold Extra-Ordinary General Meeting (EGM) of the Shareholders of the Company on Wednesday, 3rd January, 2024 at 12:00 P.M. Notice of EGM to be held on Wednesday, 3rd January, 2024 Dipna Pharmachem Limited has informed BSE about Notice of Shareholders Meeting for Extra-ordinary Meeting. (As Per BSE Announcement Dated on 11/12/2023) EGM 03/01/2024 (As Per BSE Bulletin Dated on 11.12.2023) Outcome of Extra Ordinary General Meeting held today i.e. 3rd January, 2024 in terms of the Regulations 30 of the SEBI(LODR) Regulations, 2015. (As Per BSE Announcement Dated on 03/01/2024) Scrutinizer Report for Extraordinary General Meeting of 2023-24. (As Per BSE Announcement Dated on 04.01.2024)

EGM Date: 04 Apr 2025

Pursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e., Wednesday, 12th March, 2025 at the registered office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India - 380 055 which commenced at 03:00 P.M. and concluded at 05:00 P.M. inter-alia has: 1. Considered and approved Valuation Report issued by Mr. Manish Santosh Buchasia, Registered Valuer, Ahmedabad, in accordance with Regulation 164 of SEBI (ICDR) Regulation, 2018. 2. Decided to hold Extra-Ordinary General Meeting ('EGM') of the shareholders of the Company on Friday, 4th April, 2025 at 03:00 P.M. through Video Conferences ('VC') / Other Audio-Visual Means ('OAVM'). We hereby inform you that the Board of of the Company has decided to call Extra- Ordinary General Meeting of the Company to be held on Friday, 4th April, 2025 at 3:00 P.M through Video Conferencing('VC')/ other Audio Visual Means ('OAVM') (As Per BSE Announcement dated on 13.03.2025) EGM 04/04/2025 (As Per BSE Bulletin Dated on 14.03.2025) Kindly find the attached Outcome and Summary of the Extra Ordinary (As Per BSE Announcement dated on 04.04.2025) Kindly find the attached Scrutinizer Report of the Extra Ordinary General Meeting held on 04-04-2025. (As Per BSE Announcement dated on 07.04.2025)

Dipna Pharmachem Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,692.65	₹4,06,123.43
Divis Laboratories Ltd	₹5,757.50	₹1,52,843.53
Cipla Ltd	₹1,496.50	₹1,20,859.90
Torrent Pharmaceuticals Ltd	₹3,221.20	₹1,09,015.15
Mankind Pharma Ltd	₹2,522.45	₹1,04,070.87

Dipna Pharmachem Ltd Top Mutal Funds Invested

No data available

Dipna Pharmachem Ltd News

Dipna Pharmachem EGM scheduled

On 4 April 2025

13 Mar 2025, 04:38 pm

Dipna Pharmachem to hold board meeting

On 12 March 2025

08 Mar 2025, 10:20 am

Dipna Pharmachem announces board meeting date

On 24 February 2025

12 Feb 2025, 11:34 am

Dipna Pharmachem to convene board meeting

On 6 February 2025

31 Jan 2025, 11:46 am

Dipna Pharmachem announces board meeting date

On 29 July 2024

25 Jul 2024, 10:30 am

Dipna Pharmachem Ltd Stock Analysis

Annual revenue for Dipna Pharmachem Ltd increased by 64.45% to ₹164.34 crore in FY 2024 from ₹99.93 crore in FY 2023.
Annual Net Profit for Dipna Pharmachem Ltd increased by 19.02% to ₹1.09 crore in FY 2024 from ₹0.91 crore in FY 2023.
Promoter Shareholding in Dipna Pharmachem Ltd remains unchanged by 0.00% in the most recent quarter, from 9.98% in March 2024 to 9.98% in September 2024.
Dipna Pharmachem Ltd delivered a 1-year return of 107.73% compared to the Nifty 50, which provided a return of 5.82% as of the last trading session.
Dipna Pharmachem Ltd share price moved up by 4.56% from its previous close of INR ₹16.66. The latest Dipna Pharmachem Ltd share price is INR ₹17.42.
Dipna Pharmachem Ltd share price today has been at a low of 16.30 and a high of 17.49. Over the past 52 weeks, the Dipna Pharmachem Ltd share price has seen a low of 6.40 and a high of 18.06.

FAQ’s

What is the share price of Dipna Pharmachem Ltd today?

Dipna Pharmachem Ltd share price as on 17 Apr 2025 is ₹ 17.42

What is the Market Cap of Dipna Pharmachem Ltd?

The market cap of Dipna Pharmachem Ltd stock is ₹40.06 Cr.

What is the PE Ratio of Dipna Pharmachem Ltd?

The Price to Earnings (P/E) Ratio of Dipna Pharmachem Ltd is 20.93

What is the PB Ratio of Dipna Pharmachem Ltd?

The Price to Book (P/B) Ratio of Dipna Pharmachem Ltd is 0.60

What is the 52 week high of Dipna Pharmachem Ltd Share Price?

The 52 week high of Dipna Pharmachem Ltd share price stands at ₹18.06

What is the 52 week low of Dipna Pharmachem Ltd Share Price?

The 52 week low of Dipna Pharmachem Ltd share price stands at ₹6.40

How can I buy shares of Dipna Pharmachem Ltd?

Simply open a demat account with Torus Digital and place an order to buy shares of Dipna Pharmachem Ltd.

Dipna Pharmachem Ltd Share Price

Dipna Pharmachem Ltd Summary